3 New Strong Buy Ratings from Top-Rated Analysts: 07/31/2025

Just for you — a complimentary peek at what’s behind the curtain on our Strong Buy Stocks from Top Wall Street Analysts screener:

• Vertiv Holdings (VRT) is back on the list — the reason why might surprise you
• Jabil (JBL) is currently enjoying strong upward momentum 
• Tenet Healthcare (THC) is more than just a funny ticker 

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...
The ChatGPT Moment for Money Has Arrived-Introducing NatGold  

AI changed intelligence; NatGold changes money. Digitally mined, sustainably produced, and backed by real gold reserves, NatGold is redefining how wealth is stored and traded. Reserve your tokens at a special 10% discount available only for the first 10,000 early investors-before the world wakes up.  

Act now to secure your discounted NatGold Tokens and be part of the next financial breakthrough.

1. Vertiv Holdings (NYSE: VRT) 

VRT stock offers a unique way to gain exposure to artificial intelligence. Vertiv Holdings does everything from installation and maintenance to repair when it comes to data centers. On top of that, it is one of the leading power management and, more importantly, cooling providers in the industry. With record-breaking AI CAPEX, the business is well-positioned to capture a lot of growth from a dynamic narrative.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $126.93 — get current quote > 

Max 1-year forecast: $165.00 

Why we’re watching:

• Vertiv Holdings enjoys broad, bullish support from Wall Street analysts. VRT has a total of 11 analyst ratings, split between 6 Strong Buys, 4 Buys, and 1 Hold. There are currently no Sell or Strong Sell ratings. See the ratings  
• Bank of America’s Andrew Obin (a top 8% rated analyst) recently doubled down on a Strong Buy rating, and increased his price target on VRT from $140 to $150.
• Obin backgrounded their price target hike by reminding readers that the price of Vertiv Holdings' stock dipped on 7/10 on news that Amazon Web Services had designed proprietary cooling systems.
• For their part, the analyst called the announcement "no different from prior business practices," noting that AWS will not manufacture or service the equipment and that AWS and other cloud service providers have traditionally used proprietary electrical and thermal equipment manufactured to their specifications.
• For Q2, Obin predicted 21% Y/Y organic revenue growth and a 19.1% adjusted operating margin for Vertiv Holdings, accounting for their above-consensus EPS estimate of $0.84.
• At present, Vertiv is the 7th highest-rated stock in the Electrical Equipment & Part industry, which has an Industry Rating of B.
• Based on a big-picture analysis of 115 proprietary factors, VRT ranks in the top 3% of equities — giving it a Zen Rating of A.
• Growth and Financials are Vertiv Holdings’ strongest Component Grade ratings — in both categories, the stock ranks in the top 6%.  (See all 7 Zen Component Grades here >)

2. Jabil (NYSE: JBL) 

Jabil is a crucial behind-the-scenes player helping some of the world’s biggest tech and industrial companies scale production without sacrificing speed and efficiency. It maintains a strong level of exposure to high-growth sectors such as electric vehicles and healthcare — moreover, it is currently enjoying strong upward momentum.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $225.45 — get current quote > 

Max 1-year forecast: $256.00 

Why we’re watching:

• Jabil stock is a consensus Strong Buy — as it currently has 6 Strong Buy ratings and 1 Hold rating. See the ratings
• Samik Chatterjee of JP Morgan (a top 3% rated analyst) recently doubled down on a Strong Buy rating, and increased his price forecast from $214 to a Street-high $256.
• In a Technology (Hardware and Networking) sector review note, Chatterjee predicted that "robust" cloud spending would catalyze an increase in 2H 2025 estimates for the group.
• However, the analyst cautioned that underlying end market drivers for some customer verticals "remain a concern" because they are more sensitive to the macro environment.
• JBL is the 6th highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
• Jabil shares rank in the 93rd percentile of the equities we track, giving them a Zen Rating of B.   
• In terms of the stock’s Growth and Financials Component Grade ratings, it ranks in the top 12% of equities.
• However, JBL’s biggest strength is Momentum — a category in which it ranks in the top 7% of stocks, owing to its 57.73% year-to-date (YTD) gains. (See all 7 Zen Component Grades here >)

A note from our sponsors...
Analysts Project a $14 Share Price, You Can Invest for $3.50  

Wall Street's bullish on the AI company making heart disease easier to detect-but you won't find this opportunity on the Nasdaq.   
HeartSciences (Nasdaq: HSCS) is offering investors $3.50 investment units that include one convertible preferred share and one warrant-providing investors two potential common shares.   
Based on some Wall Street analysts' projections, that amounts to a near-term 500% return potential.   

 Learn More and Invest in HeartSciences  

This is a paid advertisement for HeartSciences Regulation A+ offering. Please read the offering circular at invest.heartsciences.com.

3. Tenet Healthcare (NYSE: THC)

Tenet Healthcare is one of the largest for-profit healthcare providers in the U.S. In addition, it has managed to beat earnings estimates for 17 quarters in a row — now, management has raised guidance for the year by roughly $400 million. Moreover, the company maintains quite a strong balance sheet and has managed to secure the confidence of Wall Street analysts. Despite these promising signs, THC is still trading at an attractive valuation.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $158.31 — get current quote > 

Max 1-year forecast: $238.00 

Why we’re watching:

• THC enjoys broad analyst support — the stock currently has 8 Strong Buy ratings, 3 Buy ratings, and 2 Hold ratings. See the ratings
• Moreover, the average 12-month price forecast for Tenet Healthcare shares, currently pegged at $190.92, implies a hefty 20.6% upside.
• UBS equity researcher A.J. Rice (a top 13% rated analyst) recently doubled down on a Strong Buy rating, and increased his price target from $230 to a Street-high $238.
• At present, THC is the 5th highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of B.
• Tenet Healthcare ranks in the top 3% of the more than 4,600 stocks that we track, giving it a Zen Rating of A. 
• The company’s balance sheet is quite healthy — in terms of its Financials Component Grade rating, THC stock ranks in the 83rd percentile of equities.
• Value is another major strength of Tenet Healthcare — the stock is currently trading at a P/E ratio of just 10.31x, and ranks in the top 7% when it comes to this category.
• Last, but certainly not least, we have Sentiment — where THC ranks in the top 4% of stocks. (See all 7 Zen Component Grades here >)

What to Do Next?

• 9 Special Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.